piroxicam |
36322-90-4 |
Feldene |
Piroxicamum |
Pyroxycam |
Roxicam |
Piroftal |
BAXO |
CP-16171 |
4-Hydroxy-2-methyl-N-(pyridin-2-yl)-2H-benzoe1,2thiazine-3-carboxamide 1,1-dioxide |
CP 16171 |
CHF 1251 |
2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide |
UNII-13T4O6VMAM |
NSC 666076 |
Piroxicam (Feldene) |
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide |
13T4O6VMAM |
4-Hydroxy-2-methyl-3-(pyrid-2-yl-carbamoyl)-2H-1,2-benzothiazine 1,1-dioxide |
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid |
4-Hydroxy-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide |
MLS000069644 |
CHEBI:8249 |
MFCD00057317 |
NSC666076 |
4-hydroxy-2-methyl-N-pyridin-2-yl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide |
NSC-666076 |
NCGC00015823-02 |
Artroxicam |
Bruxicam |
Caliment |
Flogobene |
Geldene |
Improntal |
Larapam |
Piroflex |
Reudene |
Roxiden |
Sasulen |
SMR000035997 |
Solocalm |
Erazon |
Pirkam |
piroxicam usp |
Riacen |
Zunden |
Roxam |
CP-16,171 |
CAS-36322-90-4 |
DSSTox_CID_1170 |
4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1lambda6,2-benzothiazine-3-carboxamide |
DSSTox_RID_75990 |
DSSTox_GSID_21170 |
Piroxicamum INN-Latin |
Rosiden |
Felden |
Feldene Fast |
Feldene Gel |
(4-hydroxy-2-methyl-1,1-dioxobenzoe1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamid e |
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide |
4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide |
4-hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide |
(Z)-3-(hydroxy(pyridin-2-ylamino)methylene)-2-methyl-2H-benzoe1,2thiazin-4(3H)-one 1,1-dioxide |
Feldene (TN) |
CCRIS 3719 |
SR-01000000199 |
EINECS 252-974-3 |
AK1015 |
BRN 0627692 |
4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1?^{6},2-benzothiazine-3-carboxamide |
Piroxicam,(S) |
Prestwick_573 |
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid German |
Piroxicam USAN:USP:INN:BAN:JAN |
piroxicam:malonic acid |
Spectrum_001115 |
Tocris-0960 |
Piroxicam-(methyl-d3) |
Opera_ID_442 |
Piroxicam: Form Alpha1 |
Piroxicam: Form Alpha2 |
Prestwick0_000211 |
Prestwick1_000211 |
Prestwick2_000211 |
Prestwick3_000211 |
Spectrum2_001287 |
Spectrum3_000780 |
Spectrum4_000968 |
Spectrum5_001445 |
Lopac-P-5654 |
CHEMBL527 |
P 5654 |
BIDD:PXR0154 |
Lopac0_000900 |
Oprea1_714707 |
SCHEMBL13462 |
SCHEMBL21350 |
BSPBio_000221 |
BSPBio_001030 |
BSPBio_002460 |
KBioGR_000370 |
KBioGR_001315 |
KBioSS_000370 |
KBioSS_001595 |
MLS000038002 |
MLS001148207 |
MLS001304054 |
MLS004774122 |
DivK1c_000369 |
SPECTRUM1500491 |
SPBio_001293 |
SPBio_002142 |
Piroxicam (JP17/USP/INN) |
BPBio1_000245 |
GTPL7273 |
Piroxicam, >=98% (TLC) |
SCHEMBL3703617 |
Piroxicam for system suitability |
CHEMBL1518938 |
DTXSID5021170 |
BCBcMAP01_000176 |
BDBM85245 |
HMS501C11 |
KBio1_000369 |
KBio2_000370 |
KBio2_001595 |
KBio2_002938 |
KBio2_004163 |
KBio2_005506 |
KBio2_006731 |
KBio3_000719 |
KBio3_000720 |
KBio3_001680 |
NINDS_000369 |
Piroxicam 1.0 mg/ml in Methanol |
Bio1_000363 |
Bio1_000852 |
Bio1_001341 |
Bio2_000355 |
Bio2_000835 |
HMS1362D11 |
HMS1568L03 |
HMS1792D11 |
HMS1920H22 |
HMS1990D11 |
HMS2089B06 |
HMS2092A05 |
HMS2095L03 |
HMS2231G03 |
HMS3262D22 |
HMS3267I03 |
HMS3369B07 |
HMS3403D11 |
HMS3414H17 |
HMS3429L03 |
HMS3655C04 |
HMS3678H15 |
HMS3712L03 |
HMS3884C08 |
Pharmakon1600-01500491 |
BCP02919 |
HY-B0253 |
NSC_4856 |
Tox21_110231 |
Tox21_200151 |
Tox21_500900 |
BBL016493 |
CCG-36403 |
NSC757284 |
s1713 |
STK177288 |
ZINC12466469 |
ZINC51133897 |
ZINC87724780 |
AKOS000714958 |
AKOS025312555 |
AKOS026749939 |
Tox21_110231_1 |
AM84917 |
DB00554 |
KS-5322 |
LP00900 |
MCULE-1939282084 |
NSC-757284 |
SDCCGSBI-0050875.P005 |
(4-Hydroxy-2-methyl-1,1-dioxobenzoe1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamide |
2H-1,2-Benzothiazine-3-carboxamide,4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide |
3,4-Dihydro-2-methyl-4-oxo-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide |
4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide |
IDI1_000369 |
IDI1_002110 |
NCGC00015823-01 |
NCGC00015823-03 |
NCGC00015823-04 |
NCGC00015823-05 |
NCGC00015823-06 |
NCGC00015823-07 |
NCGC00015823-08 |
NCGC00015823-09 |
NCGC00015823-10 |
NCGC00015823-11 |
NCGC00015823-12 |
NCGC00015823-13 |
NCGC00015823-14 |
NCGC00015823-15 |
NCGC00015823-17 |
NCGC00015823-18 |
NCGC00015823-20 |
NCGC00015823-29 |
NCGC00021244-03 |
NCGC00021244-05 |
NCGC00021244-06 |
NCGC00021244-07 |
NCGC00021244-08 |
NCGC00021244-09 |
NCGC00188982-01 |
NCGC00257705-01 |
NCGC00261585-01 |
AC-24190 |
NCI60_022912 |
ST069379 |
BCP0726000299 |
SBI-0050875.P004 |
AB0011706 |
CAS_36322-90-4 |
Piroxicam, meets USP testing specifications |
EU-0100900 |
FT-0630590 |
FT-0673949 |
P1905 |
SW219862-1 |
EN300-70724 |
A19556 |
C01608 |
D00127 |
D70554 |
J10253 |
AB00052074-21 |
AB00052074-22 |
AB00052074_23 |
AB00052074_24 |
322P904 |
Q408676 |
SR-01000000199-3 |
SR-01000000199-5 |
SR-01000000199-9 |
W-106626 |
SR-01000000199-12 |
F0001-2399 |
Piroxicam, British Pharmacopoeia (BP) Reference Standard |
Z1259192069 |
Piroxicam, European Pharmacopoeia (EP) Reference Standard |
Piroxicam, United States Pharmacopeia (USP) Reference Standard |
Piroxicam, Pharmaceutical Secondary Standard; Certified Reference Material |
4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1$l^{6},2-benzothiazine-3-carboxamide |
4-hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-2H-1$l^{6},2-benzothiazine-3-carboxamide |
4-Hydroxy-2-methyl-3-(2-pyridylcarbamoyl)-2H-1,2-benzothiazine 1,1-Dioxide |
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzo-thiazine-3-carboxamide1,1-dioxide |
4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide1,1-dioxide |
N-(2-pyridyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide |
1044566-76-8 |
1488516-58-0 |
3-{hydroxy(pyridin-2-yl)aminomethylidene}-2-methyl-3,4-dihydro-2H-1$l^{6},2-benzothiazine-1,1,4-trione |
3-{hydroxy(pyridin-2-yl)aminomethylidene}-2-methyl-3,4-dihydro-2H-1lambda6,2-benzothiazine-1,1,4-trione |
4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1,2-dihydro-1lambda,2-benzothiazine-3-carboxamide |
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine -3-carboxamide-1,1-dioxide malonic acid |